U.S. Food and Drug Administration Center for Drug Evaluation and ResearchSkip navigation

CDER - Center for Drug Evaluation and Research Logo

Center for Drug Evaluation and Research

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

CDER ArchivesSpecific AudiencesCDER CalendarRegulatory InformationDrug InformationAbout CDERSide Navigational Buttons

Fruits of the Pediatric Initiatives:
a CDER Update

3/27/2003

Click here to start presentation



Table of Contents

Fruits of the Pediatric Initiatives: a CDER Update

Overview

Best Pharmaceuticals for Children
Act

Pediatric Exclusivity "The Carrot"

Pediatric Exclusivity

Studies Breakdown for Issued WRs

Ethical Issues

What We Have Accomplished ?

Labeled Products

Labeled Products with Significant New Information

Labeled Products with Significant New Information

Labeled Products with Significant New Information

Labeled Products with Significant New Information

Labeled Products with Significant New Information

Labeled Products with Significant New Information

Pediatric Rule Update

Pediatric Rule (Apr 99 – Dec 02)

Pediatric Rule

What Have We Learned?

To Contact Us:

Author: 

Debra Birenbaum, M.D. 

Lead Medical Officer 

Division of Pediatric Drug Development

Office of Counter-Terrorism and Pediatric Drug Development (OCTAP),

Center for Drug Evaluation and Research

Food and Drug Administration


Download presentation source [PowerPoint format]


totop.gif (1525 bytes) Back to Top   Back Back to Pediatrics Page

FDA/Center for Drug Evaluation and Research
Last Updated: April 10, 2003
Originator: OCTAP/DPDD
HTML by RMJ, MAU